"dbGAP Variable","dbGAP Study","dbGAP Variable Description"
phv00070924,"A Genome Wide Scan of Lung Cancer and Smoking","Gender: male or female"
phv00022944,"A Genome Wide Scan of Lung Cancer and Smoking","Gender: male or female"
phv00022954,"A Genome Wide Scan of Lung Cancer and Smoking","Gender: male or female"
phv00076111,"A Genome-Wide Association Study of Peripheral Arterial Disease","Gender of participant"
phv00124441,"A Multiethnic GWAS of Prostate Cancer",Gender
phv00142466,"A Multiethnic GWAS of Prostate Cancer",Gender
phv00142487,"A Multiethnic GWAS of Prostate Cancer",Gender
phv00164876,"A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic Melanoma","Gender of participant"
phv00173611,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as defined by genotype"
phv00173612,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173613,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by survey of patient/patient's parent"
phv00173631,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173632,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173633,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by survey of patient/patient's parent"
phv00173658,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as defined by genotype"
phv00173659,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173660,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by survey of patient/patient's parent"
phv00173684,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as defined by genotype"
phv00173685,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173686,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by survey of patient/patient's parent"
phv00173712,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by genotype"
phv00173713,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173714,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by survey of patient/patient's parent"
phv00173740,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by medical records"
phv00173741,"A Study of the Genetic Causes of Complex Pediatric Disorders","Gender of participant as identified by survey of patient/patient's parent"
phv00121765,"Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain","Gender of subject"
phv00076146,"Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes","Gender of participant"
phv00171927,"ADGC Genome Wide Association Study","Gender of participant"
phv00226032,"African American Breast Cancer GWAS","Gender of participant"
phv00164977,"Alcohol Dependence GWAS in European- and African Americans","Gender of participant"
phv00192277,"Alzheimer's Disease Sequencing Project (ADSP)",Sex
phv00192282,"Alzheimer's Disease Sequencing Project (ADSP)","Subject's Sex"
phv00195357,"Alzheimer's Disease Sequencing Project (ADSP)",Sex
phv00218087,"Alzheimer's Disease Sequencing Project (ADSP)",Sex
phv00073523,"AMD-MMAP Cohort Study: A Joint Genome Wide Association Study","Gender of participant"
phv00253333,"Antigen Discovery in Melanoma","Sex of subject"
phv00196258,"ARDSnet and the iSPAAR Consortium: Genetic Studies",Sex
phv00167339,"ARRA Autism Sequencing Collaboration","Gender of participant"
phv00190530,"Asian Indian Diabetic Heart Study (AIDHS)","Gender of participant"
phv00204449,"Atherosclerosis Risk in Communities (ARIC) Cohort","A. Hospital Information. GENDER Q9 [Cohort Stroke Abstraction Form, STR]"
phv00204634,"Atherosclerosis Risk in Communities (ARIC) Cohort","Sex (from FTRA22) [Cohort, Exam 2]"
phv00204711,"Atherosclerosis Risk in Communities (ARIC) Cohort","Sex (uncorrected from FTRA22) [Cohort, Exam 1]"
phv00204963,"Atherosclerosis Risk in Communities (ARIC) Cohort","Sex (From FTRA22) [Cohort, Exam 4]"
phv00207078,"Atherosclerosis Risk in Communities (ARIC) Cohort","[Reproductive history]. Sex of participant. Q10 [Health/Medical History, exam 2]"
phv00208795,"Atherosclerosis Risk in Communities (ARIC) Cohort","Sex (M, F) [Pulmonary Function Test, exam 1]"
phv00091341,"Atherosclerosis Risk in Communities (ARIC) Cohort","GENDER Q9"
phv00091486,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00092676,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00092793,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00092928,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00092976,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00094324,"Atherosclerosis Risk in Communities (ARIC) Cohort","GENDER OF PARTICIPANT Q10"
phv00095960,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00097872,"Atherosclerosis Risk in Communities (ARIC) Cohort","SEX (from FTRA22)"
phv00161301,"Autism Genome Project (AGP) Consortium - GWAS - Stage I and II","Gender of individual"
phv00167765,"Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)","Gender of participant"
phv00219152,"Autosomal recessive PGM3 mutations cause a new Congenital Disorder of Glycosylation","Gender of participant"
phv00221148,"Autosomal recessive TPP2 mutations cause a new human immunodeficiency",Sex
phv00221156,"Autosomal recessive TPP2 mutations cause a new human immunodeficiency","Gender of participant"
phv00196119,"B and T Cell Determinants of Influenza Vaccine Responses in the Elderly","Gender of participant"
phv00200346,"Baylor Hopkins Center for Mendelian Genomics (BH CMG)","Subject's gender"
phv00200351,"Baylor Hopkins Center for Mendelian Genomics (BH CMG)","Subject's gender"
phv00173359,"Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans","Sex of participant"
phv00168002,"Biology and Molecular Analysis of Human Hematopoiesis Genetics","Gender of participant"
phv00202613,"Bladder Cancer Clinical Cohorts","Gender of participant"
phv00163196,"BrainCloud: Data from Human Postmortem Brain Across the Lifespan","Gender of subject"
phv00193968,"Breakpoint Detection Using Long Insert Whole Genome Sequencing","Gender of participant"
phv00220928,"Breast Cancer Study","Gender of participant [Female]"
phv00217489,"Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC","Gender of participant"
phv00217501,"Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC","Gender of participant"
phv00217516,"Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC","Gender of participant"
phv00197315,"Bulgarian Schizophrenia Trio Sequencing Study","Gender of participant"
phv00173776,"BWH MS Genetic Collection","Gender of the participant"
phv00159013,"CALGB 80303: Genome-Wide Association Study of Advanced Pancreatic Cancer Patients","Gender. This variable indicates the self reported gender of the patient at the time of registration."
phv00159001,"Cancer Genetic Markers of Susceptibility for Bladder Cancer (CGEMS Bladder)","Gender of participant"
phv00098797,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00100302,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00100810,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00101950,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00105644,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00106545,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00108393,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00109144,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00109854,"Cardiovascular Health Study (CHS) Cohort",GENDER
phv00197398,"Cardiovascular Health Study (CHS) Cohort","Gender from a-variables table"
phv00197400,"Cardiovascular Health Study (CHS) Cohort",Gender
phv00164848,"CCDG: Dental Caries and CL/P in Guatemala","Gender of participant."
phv00171343,"CCHMC - eMERGE Data","Gender of participant"
phv00193953,"CD4+ cell transcriptional profiling by RNA sequencing","Gender of participant"
phv00173303,"Cebu Longitudinal Health and Nutrition Survey (CLHNS)","Gender of participant"
phv00066640,"CGEMS Breast Cancer GWAS","Gender of participant"
phv00082617,"CGEMS Prostate Cancer GWAS - Stage 1 - PLCO","Gender of participant"
phv00195732,"Characterization of a Metastatic Cervical Cancer Using NGS","Gender of participant"
phv00224900,"Characterization of Human Transcriptome by Computational and HTS Approaches","Gender of participant"
phv00179509,"Characterization of Pancreatic Adenocarcinoma Patients Using NGS","Gender of participant"
phv00219126,"Characterization of X Chromosome Inactivation by high-throughput sequencing","Gender of participant"
phv00195755,"Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study","Gender of participant"
phv00167790,"Cholesterol and Pharmacogenetics (CAP) Study","Gender [Male or Female]"
phv00076212,"CHOP Control CNV Study","Gender of participant"
phv00222541,"Chromothripsis in Patient WHIM-09","Gender of participant"
phv00161522,"CIDR Whole Exome Sequencing in Joubert Syndrome","Gender of participant"
phv00044647,"CIDR: Collaborative Study on the Genetics of Alcoholism (COGA)","Participant's gender"
phv00045171,"CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)",Gender
phv00045239,"CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)","Gender: male, female (see phs000004: NINDS Repository Neurologically Normal Control Collection)"
phv00051863,"CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)","Gender: male, female"
phv00075993,"CIDR: NGRC Parkinson's Disease Study","Self reported male or female."
phv00165082,"Ciliopathies Exome Sequencing Initiative","Gender of subject"
phv00196901,"CIP: Differential Response to Hydroxyurea and Incidence of Stroke in Sickle Cell Disease","Gender of participant"
phv00191155,"CIP: Obesity-Diabetes Familial Risk","Gender of participant"
phv00173910,"Clonal Evolution of Pre-Leukemic HSC Precedes Human AML","Gender of participant"
phv00195374,"Cohort-Based Genome-Wide Association Study of Glioma (GliomaScan)","Gender of participant [FEMALE, MALE]"
phv00020011,"Collaborative Association Study of Psoriasis","Sex for cases"
phv00224966,"Colon Cancer Clinical Cohorts","Gender of participant"
phv00202353,"Consanguinity and Rare Mutations Outside of MCCC Genes Underlie Non-Specific Phenotypes of MCC Deficiency","Gender of participant"
phv00174498,"Copy Number Variation in Congenital Kidney Malformations","Gender of participant"
phv00225292,"CPTAC Proteogenomic Confirmatory Study","Participant gender using the defined categories. [Male; Female; Unknown; Unspecified]"
phv00225344,"CPTAC Proteogenomic Confirmatory Study","Participant gender using the defined categories. [Male; Female; Unknown; Unspecified]"
phv00252786,CSER-MedSeq,"Gender of subject"
phv00217692,"CTLA4 haploinsufficiency and immune dysregulation",Gender
phv00217701,"CTLA4 haploinsufficiency and immune dysregulation","Subject's gender"
phv00090655,"Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)","Gender of subject"
phv00024957,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00025695,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00026039,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00027102,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Subject's gender"
phv00027796,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender (coded m or f)"
phv00028718,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender (form 001)"
phv00028966,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00029309,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender (from form 001)"
phv00030102,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender (0=male,1=female)"
phv00030340,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00030687,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00030750,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender (form 001)"
phv00030936,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender (from form 001)"
phv00031783,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Indicator: male gender"
phv00034144,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","Patient's gender"
phv00034546,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes",Gender
phv00051664,"DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","A4. Identifying information. Gender"
phv00159402,"DCEG Lung Cancer Study","Gender of participant [FEMALE, MALE]"
phv00253297,"DFCI Brown Lab CLL Sequencing Study","Gender of participant"
phv00201985,"DFCI Colorectal Cancer Cohorts","Gender of participant"
phv00201854,"Diabetes Prevention Program Genetics (DPPG)","Gender of participant"
phv00090824,"Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease",Gender
phv00142652,"Discovery of Non-ETS Gene Fusions using RNA Sequencing","Gender of participant"
phv00181136,"DNA Methylation Analysis of Prostate Cancer","Gender of subject"
phv00167279,"Dobyns DBD","Gender of participant"
phv00164734,"Drug Resistant Hypertension in African Americans' Exome","Gender of participant"
phv00090595,"Effect of Crohn's Disease Risk Alleles on Enteric Microbiota","Gender of participant"
phv00163596,"eMERGE Genome-Wide Association Studies of Obesity","Gender of subject."
phv00163767,"eMERGE Genome-Wide Association Studies of Obesity (Metabochip)","Gender of subject."
phv00182445,"eMERGE Network Combined Dataset","Gender of participant"
phv00163159,"eMERGE Network Study of Resistant Hypertension","Gender of participant."
phv00195566,"Epi4K: Gene Discovery in 4,000 Epilepsy Genomes",Gender
phv00195518,"Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies",Gender
phv00195521,"Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies","Self-declared gender of participant"
phv00201601,"Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies","Self-declared gender of participant"
phv00226818,"Epigenetic and Genetic Profiling in Lymphoma","Gender of participant"
phv00191073,"Epigenetic Marks as Peripheral Biomarkers of Autism","Gender of participant"
phv00191076,"Epigenetic Marks as Peripheral Biomarkers of Autism","Subject's gender"
phv00161708,"Epigenetic Profiling of Human Colorectal Cancer","Gender of participant"
phv00192229,"Exome Chip Study of NIMH Controls","Gender of participant"
phv00201670,"Exome Sequencing in Schizophrenia Families","Gender of participant"
phv00224938,"Exome sequencing of a family with thrombocytopenia and leukemia","Gender of participant"
phv00162961,"Exome Sequencing of arPEO","Gender of Participant"
phv00190857,"Exome Sequencing of Esophageal Adenocarcinoma","Participant gender as Male or Female"
phv00173412,"Exome Sequencing of Pleuropulmonary Blastoma","Participant's gender as Male or Female"
phv00179539,"Familial Exome Sequencing in Rare Pediatric Phenotypes","Gender of participant"
phv00202713,"Family Genomics of Congenital Heart Defects","Subject's gender"
phv00090620,"Foregut Microbiome in Development of Esophageal Adenocarcinoma","Gender of subject"
phv00164565,"Framingham Cohort","Values: Male; Female"
phv00177929,"Framingham Cohort","Participant gender"
phv00021228,"Framingham Cohort","SEX OF PARTICIPANT"
phv00024071,"Framingham Cohort",Gender
phv00073864,"Framingham SHARe Social Network",Gender
phv00156548,"FusionSeq: Finding Fusions with Paired-End RNA-Seq","Gender of participant"
phv00063727,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063759,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063791,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063823,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063855,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063887,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063919,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063951,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063983,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064015,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064047,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064079,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064111,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064143,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064175,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064207,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064239,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064271,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064303,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064335,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064367,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064399,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064431,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064463,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064495,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064527,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00064559,"GAW16 Framingham and Simulated Data","GENDER:1=MALE,2=FEMALE"
phv00064567,"GAW16 Framingham and Simulated Data",Gender
phv00073845,"GAW16 Framingham and Simulated Data",Gender
phv00051702,"GAW16 Framingham and Simulated Data","GENDER:1=MALE,2=FEMALE"
phv00051770,"GAW16 Framingham and Simulated Data","GENDER:1=MALE,2=FEMALE"
phv00051839,"GAW16 Framingham and Simulated Data","GENDER:1=MALE,2=FEMALE"
phv00058159,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058191,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058223,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058255,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058287,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058319,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058351,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058383,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058415,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058447,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058479,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058511,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058543,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058575,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058607,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058639,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058671,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058703,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058735,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058767,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058799,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058831,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058863,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058895,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058927,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058959,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00058991,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059023,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059055,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059087,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059119,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059151,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059183,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059215,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059247,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059279,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059311,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059343,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059375,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059407,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059439,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059471,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059503,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059535,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059567,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059599,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059631,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059663,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059695,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059727,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059759,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059791,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059823,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059855,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059887,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059919,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059951,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00059983,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060015,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060047,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060079,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060111,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060143,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060175,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060207,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060239,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060271,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060303,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060335,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060367,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060399,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060431,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060463,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060495,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060527,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060559,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060591,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060623,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060655,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060687,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060719,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060751,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060783,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060815,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060847,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060879,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060911,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060943,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00060975,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061007,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061039,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061071,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061103,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061135,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061167,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061199,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061231,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061263,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061295,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061327,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061359,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061391,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061423,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061455,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061487,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061519,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061551,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061583,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061615,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061647,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061679,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061711,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061743,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061775,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061807,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061839,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061871,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061903,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061935,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061967,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00061999,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062031,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062063,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062095,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062127,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062159,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062191,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062223,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062255,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062287,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062319,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062351,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062383,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062415,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062447,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062479,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062511,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062543,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062575,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062607,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062639,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062671,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062703,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062735,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062767,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062799,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062831,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062863,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062895,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062927,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062959,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00062991,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063023,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063055,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063087,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063119,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063151,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063183,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063215,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063247,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063279,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063311,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063343,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063375,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063407,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063439,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063471,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063503,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063535,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063567,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063599,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063631,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063663,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00063695,"GAW16 Framingham and Simulated Data","Gender 1: Male, 2: Female"
phv00217716,"GDNF and Anxiety","Gender of participant"
phv00202295,"GEI Studies - Psoriasis","Gender of participant"
phv00163633,"Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)","Gender of subject."
phv00163391,"Geisinger eMERGE - MyCode Project","Gender of subject."
phv00081063,"GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)","Reported gender of participant"
phv00167961,"Gene Mutation and Rescue in Congenital Diaphragmatic Hernia","Gender of participant"
phv00112391,"Genentech Lung Cancer Sequencing","Gender of participant"
phv00163921,"Genentech Whole Genome Sequencing of Four Hepatocellular Carcinoma Patients","Gender of participant"
phv00124352,"Genes and Blood Clotting Study (GABC)","Participant gender"
phv00168116,"Genetic Analysis of Hirschsprung Disease","Gender of participant"
phv00141836,"Genetic Associations in Idiopathic Talipes Equinovarus (GAIT)","Gender of participant"
phv00200422,"Genetic Basis of Pulmonary Non-tuberculous Mycobacterial Infections","Gender of participant"
phv00160299,"Genetic Basis of XMEN Disease","Gender of participant"
phv00167981,"Genetic Defects in Familial Renal Disorders","Gender of participant"
phv00217799,"Genetic Epidemiology Network of Salt Sensitivity (GenSalt)",Sex
phv00217805,"Genetic Epidemiology Network of Salt Sensitivity (GenSalt)",Sex
phv00159571,"Genetic Epidemiology of COPD (COPDGene)",Gender
phv00181331,"Genetic Heterogeneity of Diffuse Large B Cell Lymphoma",Gender
phv00195584,"Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire Sequencing","Gender of participant"
phv00173894,"Genetic Modifiers of Huntington's Disease","Gender of participant"
phv00171014,"Genetic Variation and Signatures of Natural Selection in Diverse Africans","Gender of participant"
phv00171913,"Genetic Variation and Signatures of Natural Selection in Diverse Africans","Gender of participant"
phv00071843,"Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project)","Gender: male or female"
phv00071861,"Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project)","Gender: male, female, or null children for pedigree structure"
phv00171948,"Genetics of High HDL Cholesterol","Gender of participant"
phv00168106,"Genetics of Human Developmental Brain Disorders","Gender of participant"
phv00195631,"Genetics of Inherited Muscle Disease","Gender of participant"
phv00220881,"Genetics of Inherited Muscle Disease","Gender of participant"
phv00202103,"Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics Study","Gender of participant"
phv00196236,"Genetics of Neuropsychiatric and Neurodevelopmental Disorders","Gender of participant"
phv00165039,"Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort","Gender of participant"
phv00111930,"GENEVA Genetics of Early Onset Stroke (GEOS) Study","Participant's gender"
phv00022834,"GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study",Sex
phv00218134,"Genome Sequencing of Hepatocellular Carcinoma","Gender of participant"
phv00171496,"Genome Sequencing of Pancreatic Ductal Adenocarcinoma","Gender of participant"
phv00195915,"Genome Variations Among the Aboriginals in Malaysia","Gender of participant"
phv00190278,"Genome Wide Association Study in Familial Crohn's Disease",Gender
phv00190285,"Genome Wide Association Study in Familial Crohn's Disease","Gender of participant"
phv00165551,"Genome wide association study of 24 hour urine composition in the Nurses' Health Study, Nurses' Health Study II, and the Health Professionals Follow-Up Study","Gender of participant"
phv00090329,"Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS","Gender of participant"
phv00160276,"Genome-Wide Analysis of Chronic Lymphocytic Leukemia","Gender of participant"
phv00180571,"Genome-Wide Analysis of Hypodiploid ALL",Gender
phv00159417,"Genome-Wide Association Studies in Upper Gastrointestinal Cancers (Asian)","Gender of participant [FEMALE, MALE]"
phv00161583,"Genome-Wide Association Study in Systemic Sclerosis","Subject's gender."
phv00158892,"Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland","Gender of participant"
phv00196926,"Genome-Wide Association Study of Anorexia Nervosa",Gender
phv00124464,"Genome-Wide Association Study of Beh+Âșet's Disease (Turkish)","Subject gender"
phv00091144,"Genome-Wide Association Study of Celiac Disease","Gender of Participant"
phv00200998,"Genome-wide Association Study of Myasthenia Gravis","Gender of participant"
phv00158908,"Genome-Wide Association Study of Neuroblastoma","Gender of the subject [Female, Male, Unknown]"
phv00196101,"Genome-Wide Association Study of Relapse of Childhood Acute Lymphoblastic Leukemia","Male or female"
phv00020112,"Genome-Wide Association Study of Schizophrenia","Sex: male, female"
phv00020235,"Genome-Wide Association Study of Schizophrenia","Sex: male, female"
phv00034892,"Genome-Wide Association Study of Schizophrenia","Sex: male, female"
phv00034926,"Genome-Wide Association Study of Schizophrenia","Sex (male, female)"
phv00190510,"Genomic Analysis of Pediatric Low Grade Gliomas","Gender of participant"
phv00174205,"Genomic Characterization of Meningiomas","Gender of participant"
phv00202272,"Genomic Origins and Admixture in Latinos (GOAL)","Gender of participant"
phv00222718,"Genomic Predictors of Combat Stress Vulnerability and Resilience","Gender of participant"
phv00182022,"Genomic Sequencing of Cervical Cancers","Gender of participant"
phv00162707,"Genomic Sequencing of Colorectal Adenocarcinomas","Participant's gender as Male or Female"
phv00171414,"Genomic Sequencing of Pediatric Rhabdoid Cancers","Participant gender as male or female [Male, Female]"
phv00201888,"Genomic Sequencing of Pediatric Rhabdomyosarcoma","Patient gender"
phv00179053,"Genomic Sequencing of Solitary Fibrous Tumors","Gender of participant"
phv00161534,"Genomic Wide Scans for Female Osteoporosis Genes","Sex of study subject."
phv00169062,"Genotype-Tissue Expression (GTEx)","Gender (Demography)"
phv00076466,"Genotyping 400 Samples from the NIGMS Human Variation Panels","Gender of participant"
phv00158856,"Genotyping NIGMS CEPH Samples from the United States, Venezuela, and France","Gender of participant"
phv00110716,"Genotyping NIGMS Chromosomal Aberration and Inherited Disorder Samples","Gender of participant"
phv00226956,"Ghana Prostate Study","Gender of participant"
phv00065502,"GWAS for Genetic Determinants of Bone Fragility","Gender of participant"
phv00201842,"GWAS in Fibrosing Interstitial Lung Disease","Gender of participant"
phv00172015,"GWAS of Breast Cancer in the African Diaspora","Gender of participant"
phv00192256,"GWAS of Familial Lung Cancer","Gender of participant"
phv00200111,"GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia","Gender of participant [FEMALE, MALE]"
phv00071870,"GWAS on Cataract and HDL in the PMRP","Gender of participant"
phv00077312,"GWAS on Cataract and HDL in the PMRP","Gender of participant"
phv00167516,"Health and Retirement Study (HRS)","Gender of respondent"
phv00196373,"HeLa S3 (CCL-2.2) HiC Sequencing","Gender of participant [F]"
phv00174312,"Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)",Gender
phv00201874,"High Density SNP Association Analysis of Lung Cancer","Gender of participant [Male, Female]"
phv00073646,"High Density SNP Association Analysis of Melanoma","Patient's gender"
phv00165018,"HIV-Resistant People with Hemophilia","Gender of participant"
phv00158769,"HMP Core Microbiome Sampling Protocol A (HMP-A)",Gender
phv00158770,"HMP Core Microbiome Sampling Protocol A (HMP-A)","Gender - coded fields"
phv00226789,"Human Autism Genetics and Activity Dependent Gene Activation","Gender of subject"
phv00090513,"Human Gut Microbiome in Amish Obesity","Gender of participant"
phv00090580,"Human Gut Microbiome in Crohn's Disease","Subject's gender"
phv00217674,"Human Responses to Influenza Vaccination","Sex of participant"
phv00190652,"Hypertriglyceridemia Study in Mexicans","Gender of participant"
phv00201571,"ICPCG Genome Wide Association Study of Familial Prostate Cancer","Gender of participant"
phv00171554,"Identification of Genes Involved in Familial Coronary Artery Disease","Gender of participant"
phv00201612,"Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas","Sex of subject"
phv00218099,"IgA Nephropathy GWAS (IGANGWAS)","Gender of participant"
phv00164712,"IgA Nephropathy GWAS (IGANGWAS)","Gender of participant"
phv00217650,"Immunosenescence: Immunity in the Young and Aged","Gender of participant"
phv00161465,"Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia","Gender of subject"
phv00171371,"Integration of Genomics and Transcriptomics in unselected Twins and in Major Depression","Gender of participant"
phv00171329,"International Consortium on the Genetics of Heroin Dependence",Gender
phv00088044,"International Consortium to Identify Genes and Interactions Controlling Oral Clefts","Individual's Gender"
phv00011566,"International Multi-Center ADHD Genetics Project","Gender of child"
phv00162679,"IPM BioBank GWAS","Gender of subject"
phv00024265,"Ischemic Stroke Genetics Study (ISGS)","Gender of the subject"
phv00034499,"Ischemic Stroke Genetics Study (ISGS)","Gender of participant (male or female)"
phv00168044,"Italian PBC Study","Gender of participant"
phv00172142,"Jackson Heart Study (JHS) Cohort","Gender of participant"
phv00125546,"Jackson Heart Study (JHS) Cohort","GENDER OF PARTICIPANT (M,F) Q18"
phv00125635,"Jackson Heart Study (JHS) Cohort","GENDER OF PARTICIPANT (M,F) Q18"
phv00125724,"Jackson Heart Study (JHS) Cohort","GENDER OF PARTICIPANT (M,F) Q18"
phv00125811,"Jackson Heart Study (JHS) Cohort","GENDER OF PARTICIPANT (M,F) Q18"
phv00126012,"Jackson Heart Study (JHS) Cohort","Gender of participant"
phv00127524,"Jackson Heart Study (JHS) Cohort","4: Participant's gender"
phv00202325,"Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset","Gender of participant"
phv00201446,"L1-seq and genome-wide SNP genotyping in a multiethnic Asian population","Gender of participant"
phv00218111,"Longitudinal Genome-Wide Analysis of Patients with Chronic Lymphocytic Leukemia","Gender of participant"
phv00020553,"Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration","Gender, Tier1"
phv00024092,"Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration","Gender, Tier2"
phv00171448,"Medulloblastoma exome sequence analysis","Participant's gender as Male or Female"
phv00225801,"Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes","Gender of participant"
phv00226764,"Melanoma Exome Sequencing","Gender of participant"
phv00167383,"Melanoma Genome Sequencing Project","Gender of patient [Male, Female]"
phv00174227,"Metabolism and Genetics of Hypobetalipoproteinemia","Gender of participant"
phv00090394,"Metagenomic Study of the Human Skin Microbiome Associated with Acne","Gender of participant"
phv00195886,"Methotrexate Clearance GWAS","Male or female"
phv00201962,"Minnesota Center for Twin and Family Research (MCTFR)","Gender of participant"
phv00201810,"miRNA profiles in serum and CSF of Parkinson's and Alzheimer's patients","Gender of participant"
phv00156596,"MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH)","Gender of participant"
phv00167913,"Molecular Defects in Pseudohypoparathyroidism or Related Disorders","Gender of participant"
phv00167971,"Molecular Genetic Analysis of Inherited Kidney Dysfunction","Gender of participant"
phv00071338,"Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)","Gender: male or female"
phv00071461,"Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)","Gender where 1 = male, 2 = female"
phv00165136,"Molecular Profiling of Cancer","Gender of participant"
phv00082643,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00084446,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00085782,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00086268,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00086736,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00087073,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00174586,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00175856,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00175877,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00175940,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","FAMILY COHORT: GENDER"
phv00176009,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00219022,"Multi-Ethnic Study of Atherosclerosis (MESA) Cohort",GENDER
phv00173161,"Multiethnic Cohort (MEC) Breast Cancer Genetics",Gender
phv00222601,"N.C. Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES)","Gender of participant"
phv00174514,"NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing",Gender
phv00173789,"National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (HTMCP - DLBCL)",Gender
phv00190993,"National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer (HTMCP - LC)",Gender
phv00173796,"National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Medulloblastoma",Gender
phv00173803,"National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Non-Hodgkin Lymphoma",Gender
phv00159249,"NCI Genome-Wide Association Study of Renal Cell Carcinoma","Gender of participant"
phv00201633,"NCI GWAS of Lung Cancer in Never Smokers","Gender of participant"
phv00226593,"NCI GWAS of Renal Cell Carcinoma in African Americans","Gender of participant [MALE, FEMALE]"
phv00225218,"NCI Non-Hodgkin Lymphoma GWAS","Gender of participant"
phv00225228,"NCI Non-Hodgkin Lymphoma GWAS","Gender of participant"
phv00160401,"NEI Ocular Hypertension Treatment Study (OHTS)","Gender of participant"
phv00129642,"NEIGHBOR Consortium Glaucoma GWAS","Gender 1: Male, 2: Female, 999: Missing"
phv00194003,"Neurodevelopmental Genomics: Trajectories of Complex Phenotypes","Gender of participant as identified by survey of patient/patient's parent"
phv00194909,"Neurodevelopmental Genomics: Trajectories of Complex Phenotypes","Subject's gender"
phv00197289,"Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)",Gender
phv00197294,"Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)",Gender
phv00174271,"Next Generation Mendelian Genetics: Ehlers-Danlos Syndrome Type VIII","Subject's gender"
phv00174188,"Next Generation Mendelian Genetics: Familial Hemophagocytic Lymphohistiocytosis","Gender of participant"
phv00200320,"Next Generation Mendelian Genetics: Hereditary Neurological Disorders",Gender
phv00195642,"NGS in Advanced Cancers","Gender of participant"
phv00121845,"NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of VTE)",Gender
phv00071771,"NHGRI Tumor Sequencing Project (Lung Adenocarcinoma)","Gender of participant"
phv00122007,"NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)","Subject's gender"
phv00122989,"NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)","Subject's Gender"
phv00191044,"NHLBI GO-ESP Family Studies: Pulmonary Arterial Hypertension",Gender
phv00179491,"NHLBI GO-ESP: Family Studies (Aortic Disease)","Gender of participant"
phv00179565,"NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis)","Gender of participant"
phv00181166,"NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy)","Gender of participant"
phv00182046,"NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia)","Gender of participant"
phv00196142,"NHLBI GO-ESP: Family Studies (Hematological Cancers)","Gender of participant"
phv00195790,"NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders)","Gender of participant"
phv00181914,"NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation)","Gender of participant"
phv00190418,"NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)","Values: Male; Female"
phv00179584,"NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)","Values: Male; Female"
phv00174111,"NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS)","GENDER OF PARTICIPANT"
phv00181856,"NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)","Gender of participant"
phv00159434,"NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)","Gender of participant."
phv00159440,"NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)","Gender of participant."
phv00161367,"NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP","GENDER OF PARTICIPANT"
phv00071268,"NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci","Gender: male or female"
phv00071321,"NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci","Gender: male, female, or null (children for pedigree structure)"
phv00163237,"NIA Long Life Family Study (LLFS)",Gender
phv00226846,"NIDCR Sjogren's International Collaborative Clinical Alliance (SICCA)","Gender of participant"
phv00195956,"NIDDK Drug-Induced Liver Injury Network (DILIN)",Gender
phv00202568,"NIDDK Gene discovery in FSGS","Gender of participant"
phv00202545,"NIDDK Gene discovery in VUR","Gender of participant"
phv00222305,"NIDDK Genetics of Metabolic Syndrome in an Island Population",Sex
phv00222296,"NIDDK Genetics of Metabolic Syndrome in an Island Population",Sex
phv00200477,"NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project","Gender of participant"
phv00088181,"NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project","Gender of participant"
phv00158872,"NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project","Gender of participant"
phv00024103,"NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project","Subject's gender"
phv00024162,"NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project","Subject's gender"
phv00023939,"NINDS Parkinson's Disease","Gender of the subject"
phv00024005,"NINDS Parkinson's Disease","Gender of the subject"
phv00000187,"NINDS Parkinsonism Study","Gender of the subject"
phv00024079,"NINDS Repository Cerebrovascular Disease/Stroke Study","Gender of the subject"
phv00020520,"NINDS Repository Motor Neuron Disease/ALS Study","Gender of the subject"
phv00000225,"NINDS Repository Neurologically Normal Control Collection","Gender of the subject"
phv00190672,"NINDS Stroke Genetics Network (SiGN)","Self reported gender"
phv00158808,"Northwestern NUgene Project: Type 2 Diabetes","Gender of participant"
phv00158818,"Northwestern NUgene Project: Type 2 Diabetes",Gender
phv00076097,"OMRF SLEGEN GWAS Data from European-American Women with Lupus","Gender of subject"
phv00217577,"Oncogenomics of Malignant Peripheral Nerve Sheath Tumors","Gender of participant"
phv00200964,"Osteosarcoma Genome-wide Association Study","Gender of participant [FEMALE, MALE]"
phv00220907,"Osteosarcoma Genomics","Gender of patient"
phv00196394,"PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE) - BioVU Cancer Project","Gender of participant"
phv00163089,"PAGE: Multiethnic Cohort (MEC)",Gender
phv00202812,"Paired AML Epigenetics Study on Clonality","Gender of participant"
phv00226238,"Pancreatic Cancer Case-Control Association Study",Gender
phv00076258,"Pancreatic Cancer Cohort and Case-Control Consortium (PanScan)","Gender of the participant"
phv00191088,"Pediatric Cardiac Genetics Consortium (PCGC)","Subject's gender"
phv00159878,"PGC: the PUWMa GWAS of ADHD","Gender of participant"
phv00195982,"PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)",Gender
phv00190844,"PGRN-RIKEN: Identification of Genetic Predictors of ACE Inhibitor-Associated Angioedema",Gender
phv00173383,"PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation","Gender of participant"
phv00173925,"Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study","Gender of participant"
phv00174531,"Pilocytic Astrocytoma in NF1","Gender of participant"
phv00160468,POLYGEN,"Gender of participant"
phv00160479,POLYGEN,"Gender of participant"
phv00066614,"POPRES: Population Reference Sample","Gender used by POPRES. Reported if exists, else inferred from sex linked data if successfully genotyped."
phv00172057,"PREDICT-HD Huntington Disease Study",Gender
phv00222697,"Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole","Gender of participant"
phv00167303,"Prostate Cancer Genome Sequencing Project","Gender of participant [Male, Female]"
phv00197161,"RAD50 Hypomorphism as Basis for Response to Chemotherapy",Gender
phv00174357,"Rapid Whole Genome Sequencing for Genetic Disease Diagnosis in the NICU","Gender of participant"
phv00190988,"Rare Mendelian Disease in Old Order Amish and Mennonite Patients","Participant's gender as Male or Female"
phv00224917,"Resistance studies in Lung Cancer","Gender of participant"
phv00196838,"Resource for Genetic Epidemiology Research on Aging (GERA)",Gender
phv00221173,"Responses to Varicella Zoster Virus Vaccination",Sex
phv00221179,"Responses to Varicella Zoster Virus Vaccination","Gender of participant"
phv00173541,"Retrotransposition in Colorectal Cancer","Gender of participant"
phv00167701,"Risk Assessment of Cerebrovascular Events (RACE) Study","Subject's gender"
phv00191101,"RM Epigenomics Program - Broad_Alz_and_Age-Related","Gender of participant"
phv00190495,"RNA-Seq studies of Gene Expression in Cells and Networks in FI and ACC in Autism","Gender of participant"
phv00201726,"RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease","Gender of participant"
phv00226550,"San Francisco Bay Area Latina Breast Cancer Study","Gender of participant"
phv00141809,"SardiNIA Medical Sequencing Discovery Project","Gender of individual"
phv00141813,"SardiNIA Medical Sequencing Discovery Project","Gender of individual"
phv00020794,"Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK","Participant's gender - See also GAIN - GoKinD phs000018: SEX"
phv00019965,"Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN","Participant's gender - See also NIDDK - GoKinD phs000088: SEX"
phv00221225,"Sensitivity to the subjective effects of amphetamine","Gender of participant"
phv00167357,"Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes","Participant's gender as male or female [Male, Female]"
phv00159267,"Sequencing of ETP T-ALL",Gender
phv00169041,"Sequencing of Medulloblastoma",Gender
phv00160438,"Sequencing of Retinoblastoma",Gender
phv00217965,"Sequencing of Targeted Genomic Regions Associated with Smoking","Participant gender"
phv00217898,"Shanghai Breast Cancer Genetics Study (SBCGS)","Gender of participant [female, male]"
phv00219205,"Single Cell Analysis Program - Transcriptome (SCAP-T)","Gender of the subject"
phv00090676,"Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency","Gender of participant"
phv00190468,"Small Intestine Neuroendocrine Tumors (Carcinoid Tumors)","Participant's gender as Male or Female"
phv00070936,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","Gender of participant"
phv00070997,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","Gender of participant"
phv00071047,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","Gender of participant"
phv00071105,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","Gender of participant"
phv00071155,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","Gender of participant"
phv00071213,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","Gender of participant"
phv00071823,"SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)",Gender
phv00195931,"Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia","Gender of participant"
phv00163221,"Spatiotemporal Transcriptome of the Human Brain","Gender of subjects"
phv00202080,"Spectrum of Mutations in Myeloid Neoplasms","Gender of participant"
phv00252380,"Sporadic Amyotrophic Lateral Sclerosis (ALS): Sequencing Study","Biological gender of subject"
phv00129605,"STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)","Gender of participant"
phv00167779,"Strabismus, CCDD and Other Anomalies","Gender of participant"
phv00225166,"Strong Activation of Retroviral LTRs in HCC","Gender of participant"
phv00195533,"Study of Adaptation to Hypoxia in Ethiopian Highlanders","Gender of participant"
phv00022888,"Study of Addiction: Genetics and Environment (SAGE)","Participant's gender"
phv00066544,"Study of Irish Amyotrophic Lateral Sclerosis (SIALS)","Participant's gender"
phv00066550,"Study of Irish Amyotrophic Lateral Sclerosis (SIALS)","Participant's gender"
phv00182063,"Study of Melanoma Risk in Australia and the United Kingdom",Gender
phv00167461,"Sweden-Schizophrenia Population-Based Case-Control Exome Sequencing","Gender of participant"
phv00167582,"TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2",Gender
phv00167559,"TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1",Gender
phv00167605,"TARGET: Acute Myeloid Leukemia (AML)",Gender
phv00167654,"TARGET: Cancer Model Systems (MDLS): Cell Lines and Xenografts (including PPTP)",Gender
phv00167612,"TARGET: Kidney, Clear Cell Sarcoma of the Kidney (CCSK)",Gender
phv00167661,"TARGET: Kidney, Rhabdoid Tumor (RT)",Gender
phv00167668,"TARGET: Kidney, Wilms Tumor (WT)",Gender
phv00167620,"TARGET: Neuroblastoma (NBL)",Gender
phv00167647,"TARGET: Osteosarcoma (OS)",Gender
phv00201753,"Targeted Sequencing of GWAS Loci in Cleft Lip and Palate","Gender of participant"
phv00167535,"Temporal Dissection of Tumorigenesis in Primary Cancers",Gender
phv00217592,"The Collaborative Study on the Genetics of Alcoholism (COGA)","Gender Status"
phv00217635,"The Collaborative Study on the Genetics of Alcoholism (COGA)","Gender Status"
phv00174401,"The Detroit Neighborhood Health Study (DNHS)","Gender of participant."
phv00191116,"The Familial Intracranial Aneurysm Linkage Study (FIA)",Gender
phv00191121,"The Familial Intracranial Aneurysm Linkage Study (FIA)",Gender
phv00087897,"The Finland-United States Investigation of NIDDM Genetics (FUSION) - GWAS Study","Gender of participant"
phv00171962,"The Gene Partnership (TGP) - eMERGE Data","Gender of Subject - as reported by participant"
phv00172003,"The Gene Partnership (TGP) - eMERGE Data","Gender of sample - as indicated by genotype analysis"
phv00162801,"The Genetic Architecture of Smoking and Smoking Cessation","Participant's gender"
phv00162918,"The Genetic Architecture of Smoking and Smoking Cessation","Participant's gender"
phv00178124,"The Genetic Landscape of Mutations in Burkitt Lymphoma","Gender of participant"
phv00154533,"The Genomic Complexity of Primary Human Prostate Cancer","Gender of participant"
phv00159330,"The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial","Gender (male, female)"
phv00142513,"The Glaucoma Genes and Environment (GLAUGEN) Study","NHS/HPFS/GEP: Gender"
phv00091112,"The Human Gut Microbiome and Recurrent Abdominal Pain in Children","Gender of participant"
phv00098405,"The Human Virome and Febrile Illness in Children","Gender of participant"
phv00167992,"The Molecular Basis of Inherited Reproductive Disorders","Gender of participant"
phv00195824,"The mutational characterization of adenoid cystic carcinoma","Gender of the participate"
phv00163064,"The Mutational Landscape of Head and Neck Squamous Cell Carcinoma","Participant's gender [Male, Female]"
phv00091251,"The Neonatal Microbiome and NEC","Sex of subject"
phv00091258,"The Neonatal Microbiome and NEC","Sex of subject"
phv00091161,"The Role of the Gut Microbiota in Ulcerative Colitis",Gender
phv00202243,"The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study","Gender of participant"
phv00159451,"Towards a Genomic Understanding of Myeloma","Participant's gender as Male or Female"
phv00174237,"Transcriptome Sequencing of Pediatric AML FAB-M7",Gender
phv00171438,"Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V - HTG Amsterdam","Gender of participant"
phv00226507,"Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV) Study","Gender of participant"
phv00066340,"Type 2 Diabetes in African Americans, GWAS and Exome Sequencing","Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female"
phv00066354,"Type 2 Diabetes in African Americans, GWAS and Exome Sequencing","Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female"
phv00066507,"Type 2 Diabetes Starr County GWAS and Exome Sequencing",Gender
phv00221198,"Tyrosine Kinase Mutations in Endometrial Cancer","Gender of participant"
phv00171540,"University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders)","Gender of participant"
phv00197132,"University of Michigan Clinical Sequencing Exploratory Research (CSER)","Gender of participant"
phv00197223,"University of Washington Center for Mendelian Genomics (UW-CMG)","Subject's sex"
phv00197228,"University of Washington Center for Mendelian Genomics (UW-CMG)","Subject's sex"
phv00225944,"University of Washington CSF biomarker study for Parkinson disease","Gender of participant"
phv00077277,"Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration","Gender of participant"
phv00225885,"VESPA: Genome Wide Study of Vancomycin","Gender of participant"
phv00158991,"VitGene Generalized Vitiligo Genetics Study","Gender of participant"
phv00163339,"Whole Exome and Targeted Sequencing in Tourette Syndrome Multiplex Families","Gender of participant"
phv00201705,"Whole Exome and Transcriptome Sequencing in Sporadic ALS","Gender of participant"
phv00252647,"Whole Exome Sequence of Hearing Loss Family","Gender of participant"
phv00163736,"Whole Exome Sequencing for Colorectal Cancer","Gender of participant"
phv00193922,"Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study",Gender
phv00193929,"Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study",Gender
phv00165095,"Whole Exome Sequencing of Chronic Lymphocytic Leukemia","Participant's gender as Male or Female."
phv00165116,"Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma","Participant's gender [Male or Female]"
phv00011576,"Whole Genome Association Study of Bipolar Disorder","A1. Sex. (Participants with European ancestry). DIGS2"
phv00016991,"Whole Genome Association Study of Bipolar Disorder","A1. Gender. INTERVIEWER: circle sex code. (Participants with European ancestry). DIGS4"
phv00035052,"Whole Genome Association Study of Bipolar Disorder","Sex: male, female. (Participants with European ancestry)"
phv00035338,"Whole Genome Association Study of Bipolar Disorder","Sex: male or female, (Participants with European ancestry). DIGS3"
phv00051908,"Whole Genome Association Study of Bipolar Disorder","A1 Gender, (African American participants). DIGS4"
phv00054360,"Whole Genome Association Study of Bipolar Disorder","Sex: male, female. (African American participants)"
phv00066360,"Whole Genome Association Study of Systemic Lupus Erythematosus",Gender
phv00071826,"Whole Genome Association Study of Visceral Adiposity in the HABC Study",Gender
phv00066468,"Whole Genome Association Twin Study of Myopia and Glaucoma Risk Factors","Gender of participant"
phv00195712,"Whole Genome Comparisons of Breast Cancers and their Xenotransplants","Subject's gender"
phv00191011,"Whole Genome Profiling to Detect Schizophrenia Methylation Markers","Gender status"
phv00124471,"Whole Genome Sequencing of Triple Negative Breast Cancer","Gender of participant"
phv00222265,"Whole Genome Sequencing of Two 22q11DS Trios","Gender of participant"
phv00168012,"Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma","Gender of participant"
phv00196481,"Whole-genome sequencing in multiplex epilepsy families","Self-declared gender of participant"
phv00073670,"Whole-Genome Sequencing of Acute Myeloid Leukemia","Gender of participant"
phv00252611,"XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study","Gender of participant"
phv00202582,"Yale Center for Mendelian Genomics (Y CMG)","Subject's gender"
phv00202587,"Yale Center for Mendelian Genomics (Y CMG)","Subject's gender"